glp 1 and aromatase inhibitors A new Penn Medicine study of more than 110,000 women found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not. Presented Evolution of GLP‐1 Receptor Agonists

Carrizales-Seplveda EF, Ordaz-Faras A, Vera-Pineda R, Flores-Ramrez R

This study also showed that GLP-1 and the GLP-1MK-801 conjugate promote enhanced whole-body lipid oxidation, evident by a decrease in respiratory exchange ratio (RER) compared with vehicle or MK-801 treatment (Extended Data Fig

How Ozempic may increase the risk for blood clot formation: Gastrointestinal issues: It is well known that Ozempic may cause serious gastrointestinal problems

Several firms that initially covered GLP-1 drugs for weight loss have since restricted coverage to only cover GLP-1 agonists for employees with specific medical indications, like diabetes

We also offer counseling to make sure you know how to properly take your medications